Literature DB >> 16966351

Iron deficiency in infancy predicts altered serum prolactin response 10 years later.

Barbara Felt1, Elias Jimenez, Julia Smith, Agustin Calatroni, Niko Kaciroti, Gloria Wheatcroft, Betsy Lozoff.   

Abstract

Serum prolactin may reflect CNS dopaminergic function. Because iron deficiency (ID) alters brain dopamine in rats, serum prolactin levels were previously investigated in infants with varied iron status. High serum prolactin levels correlated with behaviors typical of chronic ID. The objective of this study was to determine the effect of infant iron status on serum prolactin levels after a stressor in early adolescence. One hundred fifty-nine of 191 children enrolled in infancy (chronic ID, n = 46; good iron comparison group, n = 113) had serum prolactin measurements after catheter placement at 11-14 y of age. Serum prolactin levels were compared by sex, pubertal status and infant iron status and the pattern of change over time was compared by infant iron status controlling for pubertal stage and background factors. Males and less mature adolescents had lower serum prolactin concentrations than females and more mature adolescents. Controlling for these factors, the serum prolactin response pattern differed significantly by infant iron status. Serum prolactin declined earlier for the chronic ID group. In conclusion, an altered serum prolactin response pattern was observed 10 y after chronic ID in infancy and may suggest a long-lasting effect of ID on the regulation of prolactin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966351      PMCID: PMC1868574          DOI: 10.1203/01.PDR.0000242848.45999.7b

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  37 in total

Review 1.  Dopamine as a prolactin (PRL) inhibitor.

Authors:  N Ben-Jonathan; R Hnasko
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

2.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

Review 3.  Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects.

Authors:  N Ben-Jonathan; J L Mershon; D L Allen; R W Steinmetz
Journal:  Endocr Rev       Date:  1996-12       Impact factor: 19.871

4.  Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients.

Authors:  T Rinne; H G Westenberg; J A den Boer; W van den Brink
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

Review 5.  Prolactin and neuroimmunomodulation: in vitro and in vivo observations.

Authors:  I C Chikanza
Journal:  Ann N Y Acad Sci       Date:  1999-06-22       Impact factor: 5.691

6.  Neonatal maternally deprived rats have as adults elevated basal pituitary-adrenal activity and enhanced susceptibility to apomorphine.

Authors:  N Y Rots; J de Jong; J O Workel; S Levine; A R Cools; E R De Kloet
Journal:  J Neuroendocrinol       Date:  1996-07       Impact factor: 3.627

7.  The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function.

Authors:  M J Attenburrow; C Williams; J Odontiadis; J Powell; F Van de Ouderaa; M Williams; P J Cowen
Journal:  Psychol Med       Date:  2003-11       Impact factor: 7.723

8.  Serum steroids and prolactin during and after major surgical trauma.

Authors:  A Lindh; K Carlström; J Eklund; N Wilking
Journal:  Acta Anaesthesiol Scand       Date:  1992-02       Impact factor: 2.105

9.  Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.

Authors:  G V Shah; S W Shyr; C E Grosvenor; W R Crowley
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

10.  Iron deficiency anemia and iron therapy effects on infant developmental test performance.

Authors:  B Lozoff; G M Brittenham; A W Wolf; D K McClish; P M Kuhnert; E Jimenez; R Jimenez; L A Mora; I Gomez; D Krauskoph
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

View more
  10 in total

1.  Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder.

Authors:  Chadi Calarge; Cristan Farmer; Robert DiSilvestro; L Eugene Arnold
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

2.  Iron status in toddlerhood predicts sensitivity to psychostimulants in children.

Authors:  Catharyn A Turner; Diqiong Xie; Bridget M Zimmerman; Chadi A Calarge
Journal:  J Atten Disord       Date:  2010-10-26       Impact factor: 3.256

Review 3.  Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction.

Authors:  Betsy Lozoff
Journal:  J Nutr       Date:  2011-02-23       Impact factor: 4.798

4.  Iron Deficiency Reduces Synapse Formation in the Drosophila Clock Circuit.

Authors:  Samuel S Rudisill; Bradley R Martin; Kevin M Mankowski; Charles R Tessier
Journal:  Biol Trace Elem Res       Date:  2018-07-18       Impact factor: 3.738

5.  Long-term neuroendocrine effects of iron-deficiency anemia in infancy.

Authors:  Barbara T Felt; Patricio Peirano; Cecilia Algarín; Rodrigo Chamorro; Teresa Sir; Niko Kaciroti; Betsy Lozoff
Journal:  Pediatr Res       Date:  2012-02-15       Impact factor: 3.756

6.  Double burden of iron deficiency in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years.

Authors:  Betsy Lozoff; Elias Jimenez; Julia B Smith
Journal:  Arch Pediatr Adolesc Med       Date:  2006-11

7.  House dust concentrations of organophosphate flame retardants in relation to hormone levels and semen quality parameters.

Authors:  John D Meeker; Heather M Stapleton
Journal:  Environ Health Perspect       Date:  2010-03       Impact factor: 9.031

8.  Iron deficiency in pediatric patients in long-term risperidone treatment.

Authors:  Chadi Albert Calarge; Ekhard E Ziegler
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

9.  Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

Authors:  R Savica; B R Grossardt; J M Carlin; M Icen; J H Bower; J E Ahlskog; D M Maraganore; D P Steensma; W A Rocca
Journal:  Neurology       Date:  2009-10-27       Impact factor: 9.910

10.  Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.

Authors:  Chadi A Calarge; Vicki L Ellingrod; Laura Acion; Del D Miller; Jessica Moline; Michael J Tansey; Janet A Schlechte
Journal:  Pharmacogenet Genomics       Date:  2009-05       Impact factor: 2.089

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.